Geographical expansion is easy to show. A map gains another colour, a market name appears in the plan and the business seems to have moved beyond its previous boundaries. The commercial route is less visible. Two markets can rely on the same group for much of the proposed business, leaving an important dependency concentrated despite the wider map. That does not make expansion a mistake. It means that the institution needs a second description, one that explains how it expects to reach the opportunity and what it is choosing to rely on.
In a fictional 2016 assessment at Vaurenne Therapeutics, the model for two markets showed C$135 million in annual sales at maturity. It attributed 56% to one proposed distribution group. Those were prospective figures, not results. I supported preparing one market first, with C$2.4 million in assessment and commercial work, while keeping the second available for later consideration. The decision gave up simultaneous momentum. Its purpose was to make the initial undertaking proportionate to the evidence about the route, not to claim that a smaller geographical ambition is inherently better.
## Read the route as carefully as the map
The map and the sales model answered different questions. The first showed where the opportunity lay. The second showed how a substantial part of the proposed business would reach it. If a strategy discussion used geography as a shorthand for independent exposure, the common distribution relationship needed to be brought back into view. I wanted the reader to see both dimensions without assuming that either one invalidated the other. A company can gain useful geographical reach while accepting greater reliance on a particular counterpart.
The figure of 56% was relevant because it described the model under discussion, not because it crossed a universal threshold. Another proposal could involve a similar percentage and a different decision. The strength of the relationship, the alternatives, the intended commitment and the institution's broader context would matter. I would not turn one fictional choice into a numerical rule for pharmaceutical expansion. The strategic task is to connect the concentration with the specific undertaking being proposed, then let the responsible decision-makers judge it with the necessary specialist evidence.
Forecasts also require their own discipline in public writing. C$135 million at maturity cannot become revenue achieved merely because it is the largest number in the case. Commercial preparation is not equivalent to product permission, market entry or supply capability. Medical, regulatory, contractual and operating assessments remain with their qualified owners. I can explain how a sales model informed a strategic recommendation without suggesting that the model settled those other questions. The account becomes more useful when the number retains its period, status and limits.
## The concentrated relationship can still have value
The sponsors wanted to prepare both markets together. They argued that a combined opportunity would matter more to the distribution group and could reduce repeated effort. Their case recognised a genuine advantage of concentration: a substantial common relationship can support coordination that would be harder across fragmented routes. It would be misleading to write the story as though they had overlooked the dependence entirely and I alone had introduced responsibility. We differed about the initial commitment, not about whether relationships can create value.
I wanted more evidence before preparing the full two-market undertaking. That preference had costs. Sequential work could duplicate preparation, weaken the appeal of the immediate opportunity or delay a wider relationship. The selected approach did not eliminate those disadvantages by being more cautious. We had to accept them and explain why the narrower initial commitment remained preferable in the circumstances. A strategic decision becomes assessable when both the attraction of the rejected option and the burden of the selected one remain visible.
The relationship itself was not being labelled unreliable. A concentration assessment can be useful without predicting misconduct or failure by the counterpart. Its purpose is to understand what the business depends on and how a change in that relationship could affect its plans. Public writing should preserve that distinction, especially where an actual partner might be identifiable. In this demonstration all parties are invented. A real leader would need permission, accurate context and careful judgement about what could be disclosed without misrepresenting the counterpart or exposing confidential commercial material.
The choice of one market first also did not settle the eventual scale of the opportunity. The second remained a possible later undertaking, with its own conditions. That distinction matters because a phased proposal can be described too easily as either a retreat or an inevitable sequence. Neither is necessarily true. The institution made a present choice and preserved a future option. The future would need another assessment rather than automatic progression justified by the original map or a timetable that had outlived its assumptions.
## Describe the undertaking that is actually being chosen
The most useful strategic account states the commitment in terms that can be examined. In this case, it was C$2.4 million in assessment and commercial preparation for an initial market, alongside continued consideration of a broader direction. It was not the realisation of the C$135 million sales estimate. It was not proof that every professional condition for the business had been satisfied. Stating the undertaking at its actual scale allows the reader to understand what the recommendation achieved and what remained unresolved after it.
That approach is especially important when a leader describes expansion on a personal website. A map of countries can imply experience, reach and results that the supporting chronology does not establish. I would distinguish a market assessed from one entered, and an entry programme supported from a business whose operations I led. My role here was corporate strategy. The company had other leaders responsible for professional, contractual and operating conclusions. Naming those boundaries does not weaken the contribution; it makes the contribution precise enough for a search reader to assess.
I now ask a simple follow-up whenever a geographical account seems to do too much work: through which relationships will the proposed business actually happen? The answer may reinforce the expansion case, expose a qualification or change the initial commitment. It should not be assumed from the map. These invented figures illustrate the question rather than prescribe a market-entry method. A wider geographical presence can be worthwhile while a commercial centre remains concentrated, provided the institution understands both and chooses the undertaking on that basis.